Arbutus Biopharma (ABUS) PT Lowered to $6 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts ABUS Hot Sheet
Price: $2.64 -2.94%
Rating Summary:
7 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 3 | New: 2
Rating Summary:
7 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 3 | New: 2
Join SI Premium – FREE
H.C. Wainwright analyst Ed Arce lowered the price target on Arbutus Biopharma (NASDAQ: ABUS) to $6.00 (from $7.50) while maintaining a Buy rating.
You May Also Be Interested In
- Berenberg Downgrades Learning Technologies Group (LTG:LN) (LTTHF) to Hold
- TKP (3479:JP) PT Raised to JPY1,550 at Morgan Stanley
- JPMorgan Downgrades Grupo Bimbo SAB de CV (BIMBOA:MM) (GRBMF) to Underweight
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
